Cargando…
Data for modelling US projections of product approvals, patients treated, and product revenues for durable cell and gene therapies
The recent marketing approval of several durable gene and cell therapies (2017-2020), together with observations that 7,000 monogenic indications and many cancers were potential targets, led to concern about the potential economic impact of such therapies on the US healthcare system. Using a Markov...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844867/ https://www.ncbi.nlm.nih.gov/pubmed/35198672 http://dx.doi.org/10.1016/j.dib.2022.107891 |